Oncology Drug Value Tools From NCCN, ASCO To Get Real-World Testing

03 Dec 2015

Officials from oncology professional organizations discuss next steps in the development of their frameworks for valuing oncology drugs.

The oncology drug value frameworks being developed by the National Comprehensive Cancer Network and American Society for Clinical Oncology will be tested in clinical settings to make sure they are effective in helping physicians and patients choose treatments based on value, according to officials with the organizations.

Work is also needed to determine how discussions using the tools should be framed and carried out between patients and...